Avience Biomedicals Ltd (AVIENCE) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Avience Biomedicals Ltd reported sales of ₹25.69 Cr, operating profit of ₹7.69 Cr (OPM 29.93%) and net profit of ₹4.22 Cr for the quarter ended Mar 2026. Figures in ₹ crore, consolidated where available.
AVIENCE quarterly results (₹ Cr) Metric Mar 2025 Sep 2025 Mar 2026 Sales 24.47 26.82 25.69 Expenses 17.86 19.57 18 Operating Profit 6.61 7.25 7.69 OPM 27.01% 27.03% 29.93% Other Income 0.46 0.06 0.23 Interest 0.69 0.65 0.89 Depreciation 0.48 0.56 0.66 Profit before tax 5.9 6.1 6.37 Tax 27.63% 25.74% 33.75% Net Profit 4.27 4.54 4.22 EPS in Rs 10.59 11.26 10.47
AVIENCE profit & loss, annual (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Sales 23.83 44.92 52.46 Expenses 19.65 33.4 37.36 Operating Profit 4.18 11.52 15.1 OPM 17.54% 25.65% 28.78% Other Income 0.41 0.58 0.29 Interest 0.94 1.45 1.7 Depreciation 0.62 0.88 1.22 Profit before tax 3.03 9.77 12.47 Tax 28.71% 27.33% 29.75% Net Profit 2.16 7.1 8.75 EPS in Rs 6.58 17.61 21.71 Dividend Payout 0% 0% 0%
AVIENCE balance sheet (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Equity Capital 3.28 4.03 4.03 Reserves 2.94 18.63 27.38 Borrowings 15.13 22.16 28.93 Other Liabilities 13.18 11.6 14.2 Total Liabilities 34.53 56.42 74.54 Fixed Assets 10.25 13.1 16.06 CWIP 0.03 4.62 12.85 Investments 0.03 0.03 0.03 Other Assets 24.22 38.67 45.6 Total Assets 34.53 56.42 74.54
AVIENCE cash flows (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 1.02 3.39 5.91 Cash from Investing Activity -3.9 -9.54 -13.27 Cash from Financing Activity 2.93 10.21 5.42 Net Cash Flow 0.05 4.06 -1.95 Free Cash Flow -2.81 -5.87 -7.44 CFO/OP 29% 36% 58%
AVIENCE ratios Metric Mar 2024 Mar 2025 Mar 2026 Debtor Days 123.91 139.84 146.25 Inventory Days 290.31 176.3 217.51 Days Payable 129.94 98.06 119.89 Cash Conversion Cycle 284.29 218.07 243.86 Working Capital Days 28.64 70.29 74.1 ROCE - 34.18% 26.95%